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العالقة بني َمْنِسب تقييم منوذج االستباب ومستويات األديبونيكنت واللبتني 
واألنسولني ومنسب كتلة اجلسم املرتبط بتعدد األشكال اجلينية عند املراهقني
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abstract: Objectives: This study aimed to describe correlations between glucose, insulin and adipokine levels and 
the homeostasis model assessment (HOMA) index with regards to the presence/absence of fat mass and obesity-
associated (FTO) rs9939609 and peroxisome proliferator-activated receptor (PPAR)-y rs1801282 single nucleotide 
polymorphisms (SNPs) as indicators of body mass index in adolescents. Methods: This cross-sectional study was 
conducted between September and December 2016 in Toluca, Mexico. A total of 71 students between 14–18 years 
old were included. Various anthropometric and laboratory measurements were collected, including lipid profile, 
glucose, insulin and adipokine levels and HOMA index. The degree of association between variables was evaluated 
with regards to the presence/absence of the SNPs. Results: Leptin levels were significantly higher among female 
students (P = 0.001), although adiponectin levels did not differ significantly (P = 0.060). There were significant positive 
correlations between insulin levels and HOMA index with FTO (r = 0.391; P = 0.007 and r = 0.413; P = 0.005, respectively) 
and PPARγ (r = 0.529; P = 0.007 and r = 0.537; P = 0.007, respectively) SNPs. Leptin showed a significant positive correl- 
ation in the presence of PPARγ (r = 0.483; P = 0.007) or in the absence of both SNPs (r = 0.627; P = 0.039). However, 
adiponectin was significantly negatively correlated in the presence of FTO, either alone (r = −0.333; P = 0.024) or in 
combination with PPARγ (r = −0.616; P = 0.043). Conclusion: The presence of FTO and/or PPARγ SNPs might be related 
to a genetic predisposition to metabolic syndrome.
Keywords: Obesity; Body Mass Index; Single Nucleotide Polymorphisms; Fat Mass and Obesity Associated Protein, 
Human; Peroxisome Proliferator-Activated Receptor gamma; Adipokines.
ال�شتباب  منوذج  تقييم  وَمْن�ِشب  والديبونكتني،  والأن�شولني  اجللوكوز  م�شتويات  بني  العالقات  الدرا�شة  هذه  ت�شف  الهدف:  امللخ�ص: 
 )FTO rs9939609 و PPARγ rs1801282( ملعرفة وجود اأو عدم وجود تعدد اأ�شكال النوكليوتيدات املفردة ملورثات كتلة الدهن وال�شمنة
بح�شبانها موؤ�رسات لكتلة اجل�شم عند املراهقني. الطريقة: اأجريت هذه الدرا�شة امل�شتعر�شة ما بني �شبتمرب ودي�شمرب عام 2016م يف تولو�شا 
باملك�شيك، و�شارك فيها 71 طالبا يف عمر ما بني 18–14 عاما. ومت اإجراء عدد من القيا�شات الأنرثوبومرتية واملختربية �شملت م�شتويات 
الدهون واجللكوز والأن�شولني والأديبونيكنت وَمْن�ِشب تقييم منوذج ال�شتباب. ومت تقييم درجة العالقة بني تلك املتغريات ن�شبة ً اإىل وجود 
،)P = 0.001( اأو غياب تعدد يف اأ�شكال النوكليوتيدات املفردة. النتائج: كان م�شتوى تركيز اللبتني اأعلى ب�شورة ُمْعَتدٌّة عند الطالبات الإناث
غري اأن م�شتوى الديبونكتني مل يتغري ب�شورة ُمْعَتدٌّة )P = 0.060(. وكانت هنالك عالقات اإيجابية بني م�شتويات الن�شولني وَمْن�ِشب تقييم 
منوذج ال�شتباب وبني اأ�شكال النوكليوتيدات املفردة ملورثات كتلة الدهن وال�شمنة )r = 0.413; P= 0.005 و r = 0.391; P = 0.007، على 
التوايل(، و r = 0.537; P = 0.007( PPARγ و r = 0.529; P = 0.007، على التوايل(،  وجد هناك عالقة طردية إيجابية لهرمون الليبتني بوجود 
r = 0.483; P = 0.007) PPARγ) اأو يف غياب �شكلي النوكليوتيدات املفردة (P ;r = 0.627 = 0.039). غري اأن م�شتوى الديبونكتني كان 
.)r = -0.616; P = 0.043( PPARγ اأو يف وجود )r = -0.333; P = 0.024( يتنا�شب �شلبيا مع وجود مورثات كتلة الدهن وال�شمنة، اإما مبفرده
الوراثي  PPARγ عالقة بال�شتعداد  النوكليوتيدات املفردة ل  اأ�شكال  الدهن وال�شمنة و/اأو  اأن يكون لوجود مورثات كتلة  اخلال�صة: ميكن 
لالإ�شابة باملتالزمة الأي�شية )ال�شتقالبية(.
الكلمات املفتاحية: ال�شمنة؛ موؤ�رس كتلة اجل�شم؛ تعدد اأ�شكال النوكليوتيدات املفردة؛ الربوتني املرتبط بكتله الدهن وال�شمنة، اإِْن�شان؛ PPARγ؛ الأديبوكاينز.
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Advances in Knowledge
- Certain single nucleotide polymorphisms (SNPs) have been associated with obesity and insulin resistance. However, current data are 
conflicting regarding the roles of the fat mass and obesity-associated (FTO) rs9939609 and peroxisome proliferator-activated receptor 
(PPAR)-y rs1801282 SNPs in this regard. 
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Obesity is a multifactorial disease deter- mined by a complex interaction between genetic and environmental factors. Previous 
research has associated an obesogenic phenotype with 
the presence of specific polymorphisms also linked to 
the development of insulin resistance, diabetes mellitus 
and metabolic syndrome.1 Moreover, pancreatic function 
may be altered by mutations that cause changes in the 
activity or expression of proteins involved in the regul- 
ation of basal energy expenditure; the latter phenomenon 
is explained in part by the various mechanisms of oxid- 
ative phosphorylation. Although the effect of each indiv- 
idual gene or combination of different genetic variants 
on metabolism and thermogenesis is uncertain, this may 
explain why certain individuals have a greater tendency 
to develop metabolic disorders.2
In recent decades, efforts have intensified in the 
search for single nucleotide polymorphisms (SNPs) caus- 
ing observed changes in the signalling pathways that 
regulate metabolic processes, leading to failures in energy 
homeostasis and predisposing individuals to diabetes 
and obesity.3 Peroxisome proliferator-activated receptors 
(PPARs) are a group of nuclear receptor proteins that 
function as transcription factors. These receptors are 
present in different metabolic pathways related to energy 
homeostasis, in addition to the lipid route. So far, three 
PPAR isoforms have been identified; the PPARγ isoform, 
which is highly expressed in white adipose tissue, is 
involved in lipid storage and energy dissipation and is 
recognised to be the master regulator of adipogenesis.4 
The fat mass and obesity-associated (FTO) gene is comp- 
osed of nine exons on chromosome 16 (16q12.2).5 It was 
the first gene to be associated with obesity in genome-
wide association studies.6 Frayling et al. observed that 
adults with the FTO rs9939609 SNP had a 1.67-fold incr- 
eased risk of obesity and weighed an average of 3–4 kg 
more than those without this polymorphism.7
In Mexico, genomic studies have demonstrated 
several genetic ancestries for the local population.8 How- 
ever, this implies that there may be discrepancies in the 
role of some SNPs in the presence of obesity-related 
conditions, such as metabolic syndrome. This study 
aimed to identify correlations between glucose, insulin 
and adipokine levels and the homeostasis model assess-
ment (HOMA) index with regards to the presence or 
absence of FTO rs9939609 and PPARy rs1801282 SNPs 
as indicators of body mass index (BMI) in Mexican 
adolescents.
Methods
This cross-sectional study was conducted from Sept- 
ember to December 2016 at the Autonomous University 
of Mexico State (UAEM) in Toluca, Mexico. All adolesc- 
ents between 14–18 years old attending the Lic. Adolfo 
López Mateos Preparatory School in Toluca were invited 
to participate in the study. The exclusion criteria incl-
uded a history of smoking, being pregnant or having been 
diagnosed with a chronic or acute disease. The sample 
size was calculated as follows:9 
where n is the infinite population of available partic-
ipants (981 adolescents), z is the 95% confidence level 
(1.96), p is the estimated percentage of the studied poly- 
morphisms in the total population (30%), ε is the margin 
of error set at 11% with a replacement rate of 9%, n' is 
the required finite sample size and N is the population 
size. Based on this, the required sample size was set at 
68 adolescents.
A body composition monitor was used to measure 
the subjects’ weight (BC-533 InnerScan Body Comp-
osition Monitor®, Tanita Corp., Tokyo, Japan), while a 
standard stadiometer was used to measure height. BMI 
was calculated as weight in kg divided by height in m2. 
According to gender- and age-specific World Health 
Organization BMI classifications for adolescents, the 
participants were categorised as either normal, over-
weight (≥1 standard deviation [SD] of the z score) or 
obese (≥2 SD of the z score).10 Waist and hip circumfer-
ences were measured using a fibreglass tape to the nearest 
0.1 cm and waist-to-height and waist-to-hip ratios calcul-
ated accordingly. Blood pressure was checked by auscult-
ation using a sphygmomanometer with an appropriately 
sized cuff. Systolic and diastolic hypertension was det-
ermined according to the criteria for high blood pressure 
in children and adolescents from the National High Blood 
Pressure Education Program Working Group.11
After a fasting period of 8 hours, 3 mL of venous 
blood were drawn from participants and collected into 
BD Vacutainer® tubes (Becton, Dickinson and Co., Fran- 
klin Lakes, New Jersey, USA). Using enzymatic methods, 
concentrations of glucose, uric acid, total cholesterol, 
- The current study found that certain adipokines were significantly correlated with FTO and PPARγ expression.
Application to Patient Care
- Determining the presence or absence of FTO and PPARy SNPs among adolescents might help in the design and implementation of more 
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high-density lipoproteins (HDLs), low-density lipoproteins 
(LDLs) and triglycerides were determined according to 
the manufacturer’s instructions for each reagent assay 
kit (Randox Laboratories Ltd., Crumlin, County Antrim, 
UK). The participants’ thyroid profiles were measured 
by radioimmunoassay, whereas adiponectin, insulin and 
leptin levels were determined using the 900 series Invitr-
ogen® enzyme-linked immunosorbent assay (Thermo 
Fisher Scientific Inc., Pittsburgh, Pennsylvania, USA). 
One sample remained frozen at -70 °C until DNA extr-
action. The atherogenic index of plasma (AIP) was calcul- 
ated as total cholesterol divided by HDL. The HOMA 
index for insulin resistance was calculated as follows:12 
where fPI is fasting plasma insulin and fPG is fasting 
plasma glucose. A diagnosis of metabolic syndrome was 
based on the criteria of the International Diabetes Feder- 
ation (IDF) and adjusted for age.13 
DNA extraction was performed using the MagNA 
Pure LC 2.0 Instrument and MagNA Pure LC DNA 
Isolation Kit 1 (Roche Diagnostics GmbH, Manheim, 
Germany). Results were quantified using the N60 Nano- 
Photometer® (Implen GmbH, Munich, Germany), rep- 
orting the concentration (in μg/mL) and purity (the 
ratio of the absorbance of 260/280 nm). Genotyping 
was performed by polymerase chain reaction analysis 
in a Life ECO® thermal cycler (Bioer Technology Co. 
Ltd., Hangzhou, China). The primers and conditions 
for each polymorphism are listed in Table 1.14 Oligo-
nucleotides were designed using the PrimerQuest® 
web tool (Integrated DNA Technologies Inc., Skokie, 
Illinois, USA) and synthesised at the Institute of Bio-
technology, National Autonomous University of Mexico, 
Cuernavaca, Morelos, Mexico. The Basic Local Align- 
ment Search Tool® (National Library of Medicine, 
Bethesda, Maryland, USA) was used to verify the correct 
hybridisation. The final products were visualised in 
2% agarose gel, stained with ethidium bromide and 
digitally documented using an ultraviolet transillum-
inator system (Gel Logic 212 Pro, Carestream Health, 
Rochester, New York, USA) [Figure 1]. Sequencing 
was performed at the National Institute of Genomic 
Medicine in Mexico City to confirm the detection of 
polymorphisms as per previously described methods.14
Statistical analyses were performed using the Stat-
istical Package for the Social Sciences (SPSS), Version 
19 (IBM Inc., Armonk, New York, USA). Descriptive 
continuous data were presented as means and SDs while 
qualitative variables were expressed as percentages. 
Either the Student’s t-test or Mann-Whitney U test were 
used, depending on whether the variables were 
normally distributed. Using Pearson’s correlation coeff- 
icient, the degree of association between glucose, insulin 
and adipokine levels, AIP and HOMA index were eval- 
uated in two different settings, the first being the absence 
of either SNP and the second being the presence of either 
or both SNPs. Multivariate linear modelling was perf- 
ormed to establish the possible effect of the presence 
of polymorphisms and gender on lipid profile. A linear 
regression model weighted by gender was used to det-
ermine whether very-low-density lipoprotein (VLDL), 
LDL, HDL and triglyceride levels were predictors of 
HOMA index. A linear regression analysis was also used 
fPI × fPGHOMA index =
22.5
Figure 1: Agarose gel electrophoresis image of poly-
merase chain reaction amplification products showing 
the presence of a fat mass and obesity-associated (FTO) 
polymorphism. Lane one contains the molecular marker, 
lanes 2–8 contain amplified FTO gene DNA fragments, 
lane nine contains the positive control and lane 10 
contains the negative control.
Table 1: Primers and polymerase chain reaction cond-



















Denaturation - 10 minutes at 95 °C
15 seconds at 95 °C
30 seconds at 60 °C 
30 seconds at 72 °C
Extension end cycle - 5 minutes at 72 °C 
FTO = fat mass and obesity-associated; PPAR = peroxisome 
proliferator-activated receptor; PCR = polymerase chain reaction.
*From the National Center for Biotechnology Information database.
}× 40 cycles
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to test BMI as the dependent variable and age as the 
independent variable according to gender and weighted 
by the presence of polymorphisms. A P value of ≤0.050 
was considered statistically significant.
This study was approved by the Institutional Review 
Board of the Medical Sciences Research Center at UAEM 
(#2015/14). All subjects and their parents/guardians 
provided informed consent prior to participation in 
the study. All of the study procedures were in line 
with the ethical standards of the revised Declaration 
of Helsinki as well as the Mexican Standard for the 
Implementation of Projects of Research for Health in 
Humans (#NOM-012-SSA3-2012).
Results
A total of 71 adolescents were included in the study, 
of which 40 (56.3%) were female and 31 (43.7%) were 
male. The mean age was 15.7 ± 0.7 years and the mean 
BMI was 24.5 ± 3.8 kg/m2. Based on the IDF criteria, 
21.1% of the subjects had metabolic syndrome.13 Never-
theless, 56 adolescents (78.8%) were positive for at 
least one diagnostic criterion of metabolic syndrome, 
with high triglyceride levels being most frequently 
observed (52%). In terms of family history, 14 (19.7%) 
and 16 (22.5%) adolescents had a mother or father, 
respectively, with metabolic disease. Interesting, 39 adol- 
escents (54.9%) had relatives affected by chronic disease; 
however, none of these individuals had been diagnosed 
with hypothyroidism.
According to gender, there was a statistically signif- 
icant difference among the participants in terms of weight, 
height, waist-to-hip ratio and cholesterol, HDL, leptin and 
uric acid levels (P <0.050 each) [Table 2]. Age and leptin 
levels showed a non-parametric distribution. Although 
FTO SNPs were more frequent among females, this 
difference was not statistically significant (χ2 = 2.4671; 
P = 0.116). Similarly, there was a non-significant incr-
ease in PPARγ SNP frequency among males (χ2 = 1.2884; 
P = 0.256). There was no difference according to gender 
in terms of the presence of both SNPs (χ2 = 0.2819; 
P = 0.595) [Table 3]. According to a linear regression 
analysis weighted by gender, VLDL, HDL, LDL and tri- 
glyceride levels significantly influenced HOMA index 
(P ≤0.001). Similar results were observed among adol-
escents with FTO or PPARγ SNPs (P = 0.002) as well 
as those without PPARγ polymorphisms (P = 0.035).
Table 2: Anthropometric and laboratory variables according to gender among adolescents in Toluca, Mexico (N = 71)





Age in years 15.7 ± 0.7 15.7 ± 0.7 15.8 ± 0.7 0.525
Height in m 1.63 ± 0.09 1.57 ± 0.06 1.70 ± 0.07 ≤0.001
Weight in kg 65.8 ± 13.8 59.4 ± 9.6 74.0 ± 14.2 ≤0.001
BMI in kg/m2 24.5 ± 3.8 23.9 ± 3.8 25.3 ± 3.7 0.111
WHR 0.86 ± 0.06 0.84 ± 0.0 0.88 ± 0.06 0.006
Adiponectin in µg/nL 12.9 ± 4.4 13.8 ± 4.2 11.8 ± 4.4 0.060
Glucose in mg/dL 91.9 ± 6.4 90.7 ± 4.9 93.4 ± 7.8 0.079
Insulin in IU/mL 14.6 ± 8.3 14.5 ± 8.2 14.8 ± 8.5 0.899
HOMA index 3.03 ± 1.83 2.96 ± 1.7 3.11 ± 1.92 0.743
Cholesterol in mg/dL 168.9 ± 37.9 179.3 ± 40.2 156.0 ± 30.7 0.010
HDL in mg/dL 42.5 ± 10.7 45.7 ± 11.1 38.67 ± 8.9 0.006
Leptin in ng/mL 18.0 ± 1.6 23.3 ± 15.7 11.0 ± 14.0 0.001
LDL in mg/dL 107.1 ± 31.8 112.0 ± 34.0 100.9 ± 28.2 0.149
Triglycerides in mg/dL 131.8 ± 72.1 131.2 ± 63.3 132.5 ± 82.9 0.939
Uric acid in mg/dL 4.4 ± 1.4 3.6 ± 1.0 5.3 ± 1.3 ≤0.001
VLDL in mg/dL 19.2 ± 12.2 21.5 ± 12.5 16.3 ± 11.3 0.080
AIP 4.0 ± 0.9 4.0 ± 1.0 4.1 ± 0.8 0.743
SD = standard deviation; BMI = body mass index; WHR = waist-to-hip ratio; HOMA = homeostatic model assessment; HDL = high-density 
lipoprotein; LDL = low-density lipoprotein; VLDL = very-low-density lipoprotein; AIP = atherogenic index of plasma.
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Overall, the PPARγ SNP was present in 25 adol-
escents (35.2%) and the FTO SNP was present in 46 
(64.8%), including 11 cases (15.5%) in which both PPARγ 
and FTO SNPs were present. Neither SNP was present in 
11 individuals (15.5%). Insulin levels and HOMA index 
were statistically correlated with the presence of FTO 
(P = 0.007 and 0.005, respectively), PPARγ (P = 0.007 
each) and both SNPs combined (P = 0.039 and 0.029, 
respectively). While leptin showed a positive significant 
correlation in the presence of PPARγ (r = 0.483; P = 0.014) 
and in the absence of either SNP (r = 0.627; P = 0.039), 
adiponectin was significantly negatively correlated with 
FTO, either alone (r = −0.333; P = 0.024) or in combin-
ation with PPARγ (r = −0.616; P = 0.043) [Table 4]. A 
multivariate linear model showed that the presence of 
the SNPs were not determinants of BMI and lipid profile. 
However, the effect of gender was significant (P <0.050), 
particularly in the setting of both SNPs together (P = 0.021) 
[Table 5].
Discussion
Worldwide, various studies of different ethnic popul-
ations have shown conflicting results regarding the 
relationship between body weight and FTO and PPARγ 
polymorphisms. For example, the PPARγ Pro12Ala 
rs1801282 polymorphism has been associated with 
obesity and insulin resistance among Asian Indians; 
however, in a Chinese sample, it was reported to be a 
protective factor against type 2 diabetes and obesity.15,16 
Huang et al. found that the presence of the rs2282440-
SDC3T/T genotype alongside the rs1801282 PPARγ2 
carrier genotype was strongly associated with obesity.17 
On the other hand, Queiroz et al. found that PPARγ 
rs1801282 conferred a higher risk of altered insulin 
levels and HOMA index for insulin resistance among 
overweight adolescents.18 To some extent, the latter obs- 
ervation is consistent with the results of the present 
study.
A previous study demonstrated that circulating lipids 
in Mexican children modified the association between 
the PPARγ2 rs1801282 genotype and insulin resistance.19 
In the current study, significant associations were noted 
between HOMA index and the presence of FTO or 
PPARγ polymorphisms, taking into account the role of 
lipids and weighted by gender. In Asiatic populations, 
FTO has been associated with an increased risk of 
obesity and type 2 diabetes.20 Saldaña-Alvarez et al. 
found that FTO SNPs made differential contributions to 
obesity risk, supporting the hypothesis that mechanisms 
involving these variants are gender-dependent and that 
these changes may contribute to disease development.21 
Although the researchers evaluated different FTO SNPs 
(rs1121980, rs17817449, rs3751812, rs9930506 and 
rs17817449) to that of the present study (rs9939609), 
such findings confirm the possibility that gender is a risk 
Table 4: Correlations between glucose, insulin and adipokine levels and homeostasis model assessment index with 
body mass index-related polymorphisms among adolescents in Toluca, Mexico (N = 71)
Variable Polymorphisms 






Both FTO and PPARγ 
(n = 11)
r P value r P value r P value r P value
Glucose 0.303 0.365 0.272 0.070 0.090 0.675 0.292 0.413
Insulin 0.600 0.051 0.391 0.007 0.529 0.007 0.627 0.039
HOMA index 0.600 0.051 0.413 0.005 0.537 0.007 0.685 0.029
Leptin 0.627 0.039 0.248 0.096 0.483 0.014 0.221 0.513
Adiponectin −0.323 0.332 −0.333 0.024 −0.110 0.599 −0.616 0.043
AIP 0.721 0.012 0.463 0.001 0.192 0.368 0.487 0.154
FTO = fat mass and obesity-associated; PPAR = peroxisome proliferator-activated receptor; HOMA = homeostasis model assessment; AIP = ather-
ogenic index of plasma.
*Including the 11 adolescents with both polymorphisms.
Table 3: Frequency of body mass index-related polymor- 
phisms according to gender among adolescents in Toluca, 
Mexico (N = 71)






































FTO = fat mass and obesity-associated; PPAR = peroxisome proliferator 
-activated receptor.
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factor for obesity.17 Similarly, these results are supported 
by those of Huđek et al., who found a statistically signif- 
icant positive correlation between frequencies of high-
risk FTO genotypes in obese women (AA rs9939609, 
CC rs1421085 and GG rs17817449).22 
Díaz-Anzaldúa et al. reported that differences in 
mean BMI levels among Mexican patients with bipolar 
disorder were explained by the presence of FTO 
rs8050136 and rs9939609 genotypes.23 Another study 
showed that the locus of the FTO gene was significantly 
associated with increased BMI in indigenous Mexican 
populations.24 Muñoz-Yáñez et al. found that FTO 
rs9939609 polymorphisms were associated with obesity- 
related traits, including elevated BMI, cholesterol and 
LDL levels, tricep skinfolds and an increased waist 
circumference and waist-to-height ratio.25 In the present 
study, an extremely high percentage of adolescents had 
FTO SNPs (64.8%). Given a population of approxim-
ately nine million Mexicans aged 15–20 years old, there 
are an estimated 5,830,200 young people with FTO 
rs9939609 polymorphisms and, therefore, a corresp-
onding risk of obesity.26 
Such findings are alarming for the local healthcare 
system. Fortunately, despite a genetic predisposition 
influenced by polymorphisms, obesity is a modifiable 
condition, even with a positive genetic profile risk score.27
In the PREDIMED-NAVARRA randomised trial, PPARγ 
Pro12Ala rs1801282 carriers exhibited lower telomere 
shortening compared to those with the Pro/Pro geno-
type after five years of adherence to a Mediterranean-
style diet.28 Unfortunately, the molecular effects of a 
traditional Mexican diet have yet to be fully elucidated.
In the current study, mean HDL levels were 
significantly higher among females. However, this may 
be because the mean level for males was below recomm- 
endations reported for the Mexican population.29 In 
addition, female students also had significantly higher 
leptin levels. Although leptin is a significant predictor of 
carotid intima media thickness, previous research has 
confirmed that men suffer from higher cardiovascular-
related mortality compared to women.30,31 Such findings 
undermine the epidemiological evidence for utilising 
leptin as a prognostic tool for cardiovascular disease 
in adolescents. 
As in previous research, females in the current 
study also demonstrated significantly higher cholesterol 
levels.32 A strong correlation has been established bet- 
ween cholesterol and visceral adipose tissue as quantified 
by dual-energy X-ray absorptiometry.33 Unfortunately, 
this technique was not utilised in the present study. 
Finally, the frequency of metabolic disease among the 
parents of the studied adolescents was lower than exp- 
ected; instead, students’ relatives were found to have 
a high rate of chronic disease. However, it is unclear 
whether these individuals had lipid-related abnormalities.
It is worth noting that various researchers have 
recommended lowering BMI cut-off values for over-
Table 5: Multivariate linear model for body mass index-
related polymorphisms and gender as determinants for 
body mass index and lipid profile




FTO Pillai’s trace 0.066 1.027 0.401




Roy’s largest root 0.071 1.027 0.401
PPARγ Pillai’s trace 0.107 1.738 0.154




Roy’s largest root 0.120 1.738 0.154
Gender Pillai’s trace 0.162 2.797 0.034




Roy’s largest root 0.193 2.797 0.034
FTO × 
PPARγ
Pillai’s trace 0.105 1.697 0.163




Roy’s largest root 0.117 1.697 0.163
FTO × 
gender
Pillai’s trace 0.040 0.607 0.659




Roy’s largest root 0.042 0.607 0.659
PPARγ × 
gender
Pillai’s trace 0.032 0.477 0.752








Pillai’s trace 0.178 3.143 0.021




Roy’s largest root 0.217 3.143 0.021
FTO = fat mass and obesity-associated; PPARγ = peroxisome proliferator 
-activated receptor.
*The degrees of freedom of hypothesis and error were 4.000 and 58.000, 
respectively, for each value.
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weight and obese categories in Mexican and Asiatic 
populations.34,35 Thus, if a BMI of ≥27 kg/m2 were cons- 
idered to indicate obesity, 31% of the adolescents in 
the current study would have been considered obese. 
Males were significantly heavier than females; this was 
accordingly reflected by slight elevations in glucose 
and insulin levels and HOMA index. However, these 
differences were not significant, possibly due to simil-
arities in BMI in both genders. Therefore, further studies 
are recommended including other variables which could 
influence BMI in adolescents, such as physical activity 
and dietary habits.36 Another limitation of this study 
was the small sample size; nevertheless, investigations 
regarding associations between polymorphisms and 
clinical parameters for metabolic syndrome or obesity 
can be clinically significant in small samples.37 
Conclusion
The results of this study suggest significant positive 
correlations between insulin levels and HOMA index 
with BMI-related FTO rs9939609 and/or PPARγ rs180- 
1282 polymorphisms. Future epidemiological studies 
are recommended to determine the net causative effect 
of such gene variants so as to halt the development of 
a pandemic of obesity-related health problems. Although 
the main causes of obesity, diabetes and metabolic syndr- 
ome are lifestyle factors, the role of such polymorphisms 
could help to explain why some individuals have a greater 
tendency to develop metabolic disorders and are more 
resistant to weight control interventions than others.
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